Quantcast
Channel: WN.com - Articles related to Actelion to enter Phase II clinical development with new dual orexin receptor antagonist in patients with insomnia (Actelion Ltd)
Viewing all articles
Browse latest Browse all 480

Clinical Predictors of Outcomes in HFpEF Patients (American College of Cardiology Foundation)

$
0
0
(Source: American College of Cardiology Foundation) Study Questions: In patients with heart failure and preserved ejection fraction (HFpEF), what parameters predict clinical outcomes? Methods: This was a single-center prospective, observational cohort study investigating hemodynamic and other patient-level variables associated with New York Heart Association (NYHA) functional class and outcomes in patients with HFpEF. A total of 193 patients were enrolled and clinical parameters by physical...

Viewing all articles
Browse latest Browse all 480

Trending Articles



<script src="https://jsc.adskeeper.com/r/s/rssing.com.1596347.js" async> </script>